Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy.

Biomaterials Translational Pub Date : 2024-03-28 eCollection Date: 2024-01-01 DOI:10.12336/biomatertransl.2024.01.004
Haoyu Guo, Mingke Guo, Zhidao Xia, Zengwu Shao
{"title":"Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy.","authors":"Haoyu Guo, Mingke Guo, Zhidao Xia, Zengwu Shao","doi":"10.12336/biomatertransl.2024.01.004","DOIUrl":null,"url":null,"abstract":"<p><p>Drug therapy towards tumours often causes adverse effects because of their non-specific nature. Membrane-coated technology and membrane-coated nanoparticles provide an advanced and promising platform of targeted and safe delivery. By camouflaging the nanoparticles with natural derived or artificially modified cell membranes, the nano-payloads are bestowed with properties from cell membranes such as longer circulation, tumour or inflammation-targeting, immune stimulation, augmenting the performance of traditional therapeutics. In this review, we review the development of membrane coating technology, and summarise the technical details, physicochemical properties, and research status of membrane-coated nanoparticles from different sources in tumour treatment. Finally, we also look forward to the prospects and challenges of transforming membrane coating technology from experiment into clinical use. Taken together, membrane-coated nanoparticles are bound to become one of the most potential anti-tumour strategies in the future.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"33-45"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362346/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials Translational","FirstCategoryId":"1087","ListUrlMain":"https://doi.org/10.12336/biomatertransl.2024.01.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Drug therapy towards tumours often causes adverse effects because of their non-specific nature. Membrane-coated technology and membrane-coated nanoparticles provide an advanced and promising platform of targeted and safe delivery. By camouflaging the nanoparticles with natural derived or artificially modified cell membranes, the nano-payloads are bestowed with properties from cell membranes such as longer circulation, tumour or inflammation-targeting, immune stimulation, augmenting the performance of traditional therapeutics. In this review, we review the development of membrane coating technology, and summarise the technical details, physicochemical properties, and research status of membrane-coated nanoparticles from different sources in tumour treatment. Finally, we also look forward to the prospects and challenges of transforming membrane coating technology from experiment into clinical use. Taken together, membrane-coated nanoparticles are bound to become one of the most potential anti-tumour strategies in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
膜包纳米粒子作为肿瘤治疗的生物仿生靶向传输系统。
由于药物的非特异性,对肿瘤的药物治疗往往会产生不良反应。膜包覆技术和膜包覆纳米粒子为靶向安全给药提供了一个先进而有前景的平台。通过用天然衍生或人工修饰的细胞膜伪装纳米颗粒,纳米载荷被赋予了细胞膜的特性,如更长的循环时间、肿瘤或炎症靶向性、免疫刺激,从而增强了传统疗法的性能。在这篇综述中,我们回顾了膜包衣技术的发展,总结了不同来源的膜包衣纳米粒子在肿瘤治疗中的技术细节、理化性质和研究现状。最后,我们还展望了将膜包衣技术从实验转化为临床应用的前景和挑战。综上所述,膜包衣纳米粒子必将成为未来最具潜力的抗肿瘤策略之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
9
期刊最新文献
"Yin-Yang philosophy" for the design of anticancer drug delivery nanoparticles. Abalone shell-derived Mg-doped mesoporous hydroxyapatite microsphere drug delivery system loaded with icariin for inducing apoptosis of osteosarcoma cells. Advanced nanoparticles in osteoarthritis treatment. Artificial intelligence-enabled studies on organoid and organoid extracellular vesicles. Corrigendum: Enhanced angiogenesis in porous poly(ε-caprolactone) scaffolds fortified with methacrylated hyaluronic acid hydrogel after subcutaneous transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1